2025³â 08¿ù 09ÀÏ Åä¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > Àαⴺ½º

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
 
¸ðµÎ 92622°³ÀÇ ´º½º°¡ °Ë»öµÇ¾ú½À´Ï´Ù.



Çö´ëÂ÷, Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ½Ã¹ü»ç¾÷ Âü¿©

¼ÅŬ Ç÷§Æû ±Û·Î¹ú »ç¾÷ È®Àå ±â¹Ý ¸¶·Ã
Çö´ëÂ÷°¡ Çë°¡¸®¿¡¼­ Áö¿ª ±³Åë ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇÑ ¼ö¿äÀÀ´ä±³Åë(Demand Responsive Transport, DRT) ¿î¿µ ½Ã¹ü»ç¾÷¿¡ Âü¿©ÇÑ´Ù. ±¹³» ¼º°øÀûÀÎ ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º Á¦°ø °æÇèÀ» ¹ÙÅÁÀ¸·Î ±Û·Î¹ú ½ÃÀåÀ¸·Î ¼­ºñ½º È®´ë¸¦ ÃßÁøÇÑ´Ù´Â Á¡¿¡¼­ Àǹ̰¡ ÀÖ´Ù. Çö´ëÀÚµ¿Â÷´Â Áö³­´Þ 31ÀÏ(ÇöÁö½Ã°¢) Çë°¡¸® ±«µÉ·Ú(Gödöllő)½Ã¿¡¼­ ¿­¸° ‘Çë°¡¸® ¼ö¿äÀÀ´ä±³Åë ¼­ºñ½º °³Åë½Ä’¿¡¼­ ÃÖ÷´Ü ¼ö¿äÀÀ´ä±³Åë Ç÷§ÆûÀ» Á¦°øÇϰí, ±Û·Î¹ú »ç¾÷ È®Àå ±â¹ÝÀ» ¸¶·ÃÇÑ´Ù°í 3ÀÏ(ÀÏ) ¹àÇû´Ù. °³Åë½Ä¿¡ µû¶ó 8¿ù 18ÀϺÎÅÍ 10¿ù ...

¡®±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡¡¯ ¸ðÁý¡¦ÀÏ±Þ 100¸¸¿ø

ÀâÄÚ¸®¾Æx¾Ë¹Ù¸óxǪ¶ó´ß º¹³¯ ÀÌ»ö¾Ë¹Ù
ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸ó(´ëÇ¥ÀÌ»ç À±ÇöÁØ)ÀÌ º¹³¯À» ¸Â¾Æ ġŲ Àü¹® ºê·£µå Ǫ¶ó´ß ġŲ°ú ÇÔ²² ÀÌ»ö ¾Ë¹Ù¸¦ ¸ðÁýÇÏ´Â À̺¥Æ®¸¦ ÁøÇàÇÑ´Ù°í 21ÀÏ ¹àÇû´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ³»´Þ 3ÀϱîÁö Ǫ¶ó´ß ġŲ°ú Çù¾÷ÇØ º¹³¯ ±â³ä ÀÌ»ö °ø°í¸¦ ³»°í ‘±ñdzġŲ »À ¹Ù¸¦ ¾Ë¹Ù¸ó’°ú ‘±ñdzġŲ »À ¹ß¶ó¹ö¸± ¹ß°ñ Àü¹®°¡’¸¦ ¸ðÁýÇÑ´Ù. À̹ø À̺¥Æ®´Â ¾Ë¹Ù¸óÀÌ ÁøÇà ÁßÀÎ ´ë±Ô¸ð ÇÁ·Î¸ð¼Ç ‘2025 ¿©¸§ ¾Ë¹Ù Æä½ºÅ¸(¿©¾ËÆä)’ÀÇ ÀÏȯÀÌ´Ù. ÀâÄÚ¸®¾Æ¿Í ¾Ë¹Ù¸óÀº ¿©¸§Ã¶ ¹«´õÀ§¿Í ²ß²ßÇÑ ³¯¾¾·Î ÁöÃÄ ÀÖ´Â ±¸Á÷ÀÚµéÀ» À§ ...

Novotech Report: How In-Vivo CAR-T May Reshape Cell Therapy Econo...
SYDNEY -- With in-vivo CAR-T therapies gaining global momentum, a new whitepaper from Novotech, a leading global full-service clinical Contract Research Organization (CRO) and scientific advisory company, offers insight into this next frontier of immunotherapy. In-Vivo CAR Therapies - Global Research and Development Landscape (2025) report explores the accelerating innovation in in-vivo CAR-T (Chimeric Antigen Receptor) technologies and their potential to reshape treatment across oncology, autoi ...
ÇÑÈ­±×·ì ¡®Å¸ÀÓ ¼¼°è ¿µÇâ·Â ÀÖ´Â 100´ë ±â¾÷¡¯ ¼±Á¤ (2024-06-08)
Å¿õ·ÎÁ÷½º, ¼Ò¿Ü°èÃþ ¾Æµ¿ À§ÇÑ ÈÄ¿ø¹°Ç° ±âºÎ (2024-03-07)
ÇÔ²² °¡²Ù´Â ±Ã±È½£, ±Ã±È½£ÀÇ Ä£±¸°¡ µÇ¾îÁÖ¼¼¿ä (2024-04-20)
H&M ¡®°¡¸ÕÆ® ÄÝ·ºÆÃ ´õºí ÇýÅà ķÆäÀΡ¯ (2024-05-12)
Neuraptive Therapeutics Inc. Receives Orphan Drug Designatio... (2024-01-18)
FourKites and Mitsui Appoint MKI as Exclusive Reseller in Ja... (2023-04-14)
Kioxia to Achieve Net-zero Greenhouse Gas Emissions by 2050 (2023-04-14)
¼­¿ï¿¬±¸¿ø¿¡ ¼÷Á¦¸¦ ÁÖ¼¼¿ä (2023-09-20)
Three Leading Risk Companies Unite Under New G2 Risk Solutio... (2024-01-13)
'µ¶¹ÚÅõ¾î¡¯ ±è´ëÈñ, ½ÄŽ Æø¹ß½ÃŰ´Â ±èÁØÈ£ ÇâÇØ ¡®°æ°í¡¯ (2024-01-13)
¡®¸ðµ¨ÄÚ¸®¾Æ ºí·¢ÆÀ¡¯ °Å¸® ÆÐ¼Ç¼î °ø¿¬ (2024-05-07)
¿ì¸®ÀºÇà, »ý¼ºÇü AI Ȱ¿ëÇÑ ¾÷¹«½Ã½ºÅÛ °íµµÈ­ ÃßÁø (2024-07-12)
LGÈ­ÇÐ, ¸ð·ÎÄÚ¿¡ LFP ¾ç±ØÀç °øÀå Áþ´Â´Ù (2023-10-02)
¸ðµç °¡´É¼ºÀ» À§ÇÑ ÆÐ¼Ç¡¦ ÇÏÆ¼½ºÆ® 6±â ¾Ú¹è¼­´õ ¸ðÁý (2024-04-27)
2³â ¿¬¼Ó ¡®¿ÃÇØÀÇ ºê·£µå ´ë»ó¡¯ ÇÑ¡¤Áß 2°ü¿Õ ¼ö»ó (2023-09-27)
NTT and Qualcomm Team up to Drive AI at the Edge (2023-09-27)
Å©¸°ÅäÇǾÆ, °Ü¿ï¿Ê Àå±â º¸°ü ¡®ÀÇ·ùº¸°ü ¼­ºñ½º¡¯ Á¦°ø (2024-03-09)
õȣ¿£Äɾî, ¡®À¯±â³ó È¿¼Ò ºñ¿òä¿ò¡¯ Ãâ½Ã (2022-08-19)
Wishcompany Reports 30% Sales Growth in 2023, Led by Expansi... (2024-03-04)
Ç㼺ÅÂXÀÌȣö, ¡°¾ÆÁ÷µµ ±øÆÐ·Î ¿ÀÇØÇÏ´Â »ç¶÷ ¸¹¾Æ¡± (2024-06-05)
TAYLOR SWIFT | THE ERAS TOUR Concert Film Crosses $100 Milli... (2023-10-09)
[°æÁ¦] ÇÉÅ×Å© ½Ã´ë ±ÝÀ¶Çõ½ÅÀÇ ¹°²¿, ÀÎÅͳÝÀü¹®ÀºÇà (2015-11-10)
Çö´ëÂ÷±×·ì Çù·Â»ç ¿Â¶óÀΠä¿ë¹Ú¶÷ȸ (2022-10-31)
´ÙÀÓ·¯ Æ®·° ÄÚ¸®¾Æ, 2024 Äð ¿©¸§ ¼­ºñ½º Ä·ÆäÀÎ (2024-07-19)
»ê¾÷ºÎ-KOTRA, ¡®ÇÑ-Áß Â÷¼¼´ë ¸ðºô¸®Æ¼ Çù·Â ÇöóÀÚ¡¯ °³ÃÖ (2024-05-31)
       [ÀÌÀü][1]....[676][677][678][679][680][681][682][683][684]...[3705][´ÙÀ½]

°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ
 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..